Mirtazapine and Prazosin in a 65-Year-Old with Cardiac Disease, PTSD, and Nightmares
In a 65-year-old patient with cardiac disease and PTSD-related nightmares, prazosin remains the first-line pharmacologic agent for nightmares despite mixed evidence, starting at 1 mg at bedtime with careful blood pressure monitoring, while mirtazapine (15 mg at bedtime) is a safe adjunctive option for comorbid depression, anxiety, and sleep disturbance. 1, 2, 3
Prazosin Dosing and Titration
Initial Dosing
- Start at 1 mg at bedtime 4, 5
- Monitor blood pressure after the first dose due to first-dose hypotension risk, particularly critical in this patient with cardiac disease 4, 6
- The cardiac disease requires extra caution but is not an absolute contraindication
Titration Schedule
- Increase by 1-2 mg every 3-7 days based on nightmare response and tolerability 5
- Target dose: 7-10 mg for women, 15-16 mg for men (this patient would target 15-16 mg) 1
- Maximum dose: 20 mg at bedtime, though some patients may require up to 40 mg 4, 7
- Consider split dosing (bedtime plus mid-morning 5 mg dose) if nightmares persist 1, 5
Critical Monitoring for Cardiac Patients
Blood pressure monitoring is essential:
- Check orthostatic vital signs before each dose increase 6, 8
- Monitor for dizziness, syncope, or falls 1
- If patient is on other alpha-1 antagonists (carvedilol, doxazosin), use slower titration with more frequent monitoring 6
Important Caveats About Prazosin Efficacy
The evidence for prazosin is notably mixed. A large 2018 VA study (n=304) showed no benefit over placebo 1, leading to a downgraded recommendation. However, multiple smaller studies demonstrated significant efficacy 1. The key insight: 78% of patients in the negative VA study were on concurrent antidepressants, which may have reduced prazosin's effectiveness 1. Studies show decreased prazosin response when combined with SSRIs 1.
Despite the mixed evidence, prazosin remains the first-choice pharmacologic agent because many patients respond dramatically, and alternatives have even less evidence 1.
Mirtazapine Dosing and Role
Dosing Protocol
- Start at 15 mg once daily at bedtime 3
- If inadequate response after 1-2 weeks, increase to 30 mg, then up to maximum 45 mg 3
- Do not increase more frequently than every 1-2 weeks 3
Specific Benefits in This Patient
Mirtazapine offers multiple advantages for this clinical scenario:
- Safe in cardiovascular disease - extensively studied in heart failure and coronary disease 2
- Treats comorbid depression and anxiety common in PTSD 2, 9
- Improves sleep quality and appetite 2
- May augment PTSD treatment when combined with other agents 9
- Lower QTc prolongation risk compared to SSRIs like citalopram 2
Monitoring for Mirtazapine
- Screen for bipolar disorder history before initiating 3
- Monitor for sedation, weight gain, and cognitive effects 2
- Allow 6 weeks for full antidepressant effect 2
- Taper gradually when discontinuing rather than stopping abruptly 3
Combined Treatment Strategy
The optimal approach uses both medications:
- Start prazosin first at 1 mg at bedtime with blood pressure monitoring
- Add mirtazapine 15 mg at bedtime after prazosin is stable (3-7 days), particularly if depression, anxiety, or poor appetite are present
- Titrate prazosin to 15-16 mg over 4-8 weeks based on nightmare response
- Increase mirtazapine to 30-45 mg if mood/anxiety symptoms persist after 2-4 weeks
Drug Interaction Considerations
- Avoid combining with MAOIs - requires 14-day washout period 3
- If patient requires CYP3A4 inhibitors (clarithromycin, ketoconazole), decrease mirtazapine dose 3
- If on cimetidine, decrease mirtazapine dose 3
- The combination of prazosin and mirtazapine does not have significant pharmacokinetic interactions
Critical Pitfalls to Avoid
- Undertitrating prazosin - Many clinicians stop at 2-4 mg when 15-20 mg may be needed 5, 7
- Stopping prazosin prematurely - Nightmares often return when discontinued 1
- Ignoring blood pressure in cardiac patients - First-dose hypotension can cause falls 4, 6
- Using tricyclic antidepressants or MAOIs instead of mirtazapine - These have significant cardiac risks 2
- Expecting immediate results - Prazosin may take 2-4 weeks at target dose; mirtazapine takes 4-6 weeks 2, 5
When to Reassess
- If no improvement after 8 weeks at target prazosin dose (15-20 mg), consider alternative alpha-1 antagonists (doxazosin, terazosin) 10, 11
- If concurrent SSRI use, prazosin may be less effective - consider trauma-focused psychotherapy as primary intervention 1
- Trauma-focused cognitive behavioral therapy and image rehearsal therapy remain the most evidence-based treatments and should be pursued regardless of medication choices 1